Uploaded November 2025 | Updated September 2026, 3 weeks ago
Disclaimer: I am not affiliated with Labcorp. My girlfriend works for the company and gave me the T-shirt.
Videos
youtu.be/6hL6Ef4cD78
youtu.be/RUEQ0TtjlDA
youtu.be/P9pYHfYaqME
youtu.be/HBCxY8PnLZ8
youtu.be/iPsivIbsi-Y
Sources
1. Ryu YC, Lee DH, Shim J, et al. KY19382, a novel activator of Wnt/β-catenin signaling, promotes hair re-growth and hair follicle neogenesis. Accessed November 3, 2025. authorea.com/users/333112/articles/459387-ky19382-a-novel-activator-of-wnt-%CE%B2-catenin-signaling-promotes-hair-re-growth-and-hair-follicle-neogenesis?commit=648b16f4cab7566f98fe2417ef9812f709b2c692
2. Blog. Accessed November 3, 2025. dermaregeon.com/post/hairregeon-ptd-dbm-hair-booster-a-revolutionary-approach-to-hair-restoration
3. Main. CK Regeon Inc. Accessed November 3, 2025. ckregeon.com
4. Leirós GJ, Attorresi AI, Balañá ME. Hair follicle stem cell differentiation is inhibited through cross‐talk between Wnt/β‐catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol. 2012;166(5):1035-1042. doi:10.1111/j.1365-2133.2012.10856.x
5. Lee SH, Kim MY, Kim HY, et al. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015;212(7):1061-1080. doi:10.1084/jem.20141601
6. Kim H, Choi S, Yoon J, et al. Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy. EMBO Mol Med. 2016;8(4):375-387. doi:10.15252/emmm.201505714
7. Ji-young S. Korean scientists develop potential drug candidate for hair loss. The Korea Herald. November 21, 2017. Accessed November 3, 2025. koreaherald.com/article/1510736
8. Kim D, Garza LA. The Negative Regulator CXXC5: Making WNT Look a Little Less Dishevelled. Journal of Investigative Dermatology. 2017;137(11):2248-2250. doi:10.1016/j.jid.2017.07.826
9. Lee SH, Seo SH, Lee DH, Pi LQ, Lee WS, Choi KY. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. J Invest Dermatol. 2017;137(11):2260-2269. doi:10.1016/j.jid.2017.04.038
10. Mun-hee C. Korean Scientists Develop Potential Drug Candidate for Hair Loss. Businesskorea. November 22, 2017. Accessed November 2, 2025. https://www.businesskorea.co.kr/news/articleView.html?idxno=19896
11. Premanand A, Reena Rajkumari B. Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia. Arch Dermatol Res. 2018;310(5):391-399. doi:10.1007/s00403-018-1826-8
12. Thought F. PTD-DBM Update: Q&A With Dr. Kang-Yell Choi. Follicle Thought. July 29, 2019. Accessed November 3, 2025. folliclethought.com/newsite/ptd-dbm-update-qa-with-dr-kang-yell-choi
13. Choi BY. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss. Int J Mol Sci. 2020;21(14):4915. doi:10.3390/ijms21144915
14. Zhang Y, Zu D, Chen Z, Ying G. An update on Wnt signaling pathway in cancer. Transl Cancer Res. 2020;9(2):1246-1252. doi:10.21037/tcr.2019.12.50
15. Ryu YC, Kim Y rin, Park J, et al. Wnt/β-catenin signaling activator restores hair regeneration suppressed by diabetes mellitus. BMB Reports. 2022;55(11):559-564. doi:10.5483/BMBRep.2022.55.11.081
16. Ryu YC, Park J, Kim YR, et al. CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2. Cells. 2023;12(4):555. doi:10.3390/cells12040555
17. Inc CR. [헬스코리아뉴스] 발상 전환 일으킨 씨케이리제온 … ‘재생=바이오의약품’ 통념 깬 바이오벤처. CK Regeon Inc. October 1, 2025. Accessed November 3, 2025. ckregeon.com/?kboard_content_redirect=73
Disclaimer: I am not affiliated with Labcorp. My girlfriend works for the company and gave me the T-shirt.
Videos
youtu.be/6hL6Ef4cD78
youtu.be/RUEQ0TtjlDA
youtu.be/P9pYHfYaqME
youtu.be/HBCxY8PnLZ8
youtu.be/iPsivIbsi-Y
Sources
1. Ryu YC, Lee DH, Shim J, et al. KY19382, a novel activator of Wnt/β-catenin signaling, promotes hair re-growth and hair follicle neogenesis. Accessed November 3, 2025. authorea.com/users/333112/articles/459387-ky19382-a-novel-activator-of-wnt-%CE%B2-catenin-signaling-promotes-hair-re-growth-and-hair-follicle-neogenesis?commit=648b16f4cab7566f98fe2417ef9812f709b2c692
2. Blog. Accessed November 3, 2025. dermaregeon.com/post/hairregeon-ptd-dbm-hair-booster-a-revolutionary-approach-to-hair-restoration
3. Main. CK Regeon Inc. Accessed November 3, 2025. ckregeon.com
4. Leirós GJ, Attorresi AI, Balañá ME. Hair follicle stem cell differentiation is inhibited through cross‐talk between Wnt/β‐catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol. 2012;166(5):1035-1042. doi:10.1111/j.1365-2133.2012.10856.x
5. Lee SH, Kim MY, Kim HY, et al. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015;212(7):1061-1080. doi:10.1084/jem.20141601
6. Kim H, Choi S, Yoon J, et al. Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy. EMBO Mol Med. 2016;8(4):375-387. doi:10.15252/emmm.201505714
7. Ji-young S. Korean scientists develop potential drug candidate for hair loss. The Korea Herald. November 21, 2017. Accessed November 3, 2025. koreaherald.com/article/1510736
8. Kim D, Garza LA. The Negative Regulator CXXC5: Making WNT Look a Little Less Dishevelled. Journal of Investigative Dermatology. 2017;137(11):2248-2250. doi:10.1016/j.jid.2017.07.826
9. Lee SH, Seo SH, Lee DH, Pi LQ, Lee WS, Choi KY. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. J Invest Dermatol. 2017;137(11):2260-2269. doi:10.1016/j.jid.2017.04.038
10. Mun-hee C. Korean Scientists Develop Potential Drug Candidate for Hair Loss. Businesskorea. November 22, 2017. Accessed November 2, 2025. https://www.businesskorea.co.kr/news/articleView.html?idxno=19896
11. Premanand A, Reena Rajkumari B. Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia. Arch Dermatol Res. 2018;310(5):391-399. doi:10.1007/s00403-018-1826-8
12. Thought F. PTD-DBM Update: Q&A With Dr. Kang-Yell Choi. Follicle Thought. July 29, 2019. Accessed November 3, 2025. folliclethought.com/newsite/ptd-dbm-update-qa-with-dr-kang-yell-choi
13. Choi BY. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss. Int J Mol Sci. 2020;21(14):4915. doi:10.3390/ijms21144915
14. Zhang Y, Zu D, Chen Z, Ying G. An update on Wnt signaling pathway in cancer. Transl Cancer Res. 2020;9(2):1246-1252. doi:10.21037/tcr.2019.12.50
15. Ryu YC, Kim Y rin, Park J, et al. Wnt/β-catenin signaling activator restores hair regeneration suppressed by diabetes mellitus. BMB Reports. 2022;55(11):559-564. doi:10.5483/BMBRep.2022.55.11.081
16. Ryu YC, Park J, Kim YR, et al. CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2. Cells. 2023;12(4):555. doi:10.3390/cells12040555
17. Inc CR. [헬스코리아뉴스] 발상 전환 일으킨 씨케이리제온 … ‘재생=바이오의약품’ 통념 깬 바이오벤처. CK Regeon Inc. October 1, 2025. Accessed November 3, 2025. ckregeon.com/?kboard_content_redirect=73
